This is unpublished

W. Conrad
Liles
MD
PhD

W. Conrad Liles

(206) 221-6965

1959 NE Pacific Street, Box 356420, Seattle, WA 98195

Faculty
Pinned
Academic
Professor, Department of Medicine, Division of Allergy and Infectious Diseases
Adjunct Professor, Department of Global Health
Adjunct Professor, Department of Pathology
Adjunct Professor, Department of Pharmacology
Co-Director, Molecular Medicine and Mechanisms of Disease (M3D) Graduate Program
Co-Director, Molecular Medicine Training Program, University of Washington
Associate Chair, Department of Medicine

Biography

Dr. Liles returned to the University of Washington in 2012 from the University of Toronto, where he was Vice-Chair and Professor of Medicine, Director of the Division of Infectious Diseases, and the Canada Research Chair in Infectious Diseases and Inflammation. In addition to his duties as Professor and Associate Chair, Dr. Liles serves as Co-Director of the Molecular Medicine Training Program at the University of Washington.

Education & Training

MD, University of Washington, Seattle WA (1987)

PhD, University of Washington, Seattle WA (1987)

Residency, Massachusetts General Hospital, Boston MA (1987-1990)

Chief Residency, University of Washington Medical Center, Seattle WA (1990-1991)

Fellowship in Infectious Diseases, University of Washington, Seattle WA (1991-1994)

Honors

Elected member, Association of American Physicians (AAP)

Elected member, American Clinical and Climatological Association (ACCA)

Fellow, American College of Physicians (ACP)

Fellow, Infectious Diseases Society of America (IDSA)

Canada Research Chair in Inflammation and Infectious Diseases (2006-2012)

Fialkow Scholar Award (1998)

Research Interests

  • Innate immunity
  • Molecular pathogenesis of organ injury
  • Acute lung injury/ARDS
  • Acute kidney injury (AKI)
  • Endothelial cell biology
  • Sepsis
  • Malaria
  • Immunopathogenesis ofinfectious diseases
  • Phagocyte biology

Clinical Interests

  • Tropical medicine
  • Zoonoses
  • Congenital immunodeficiency disorders
  • General infectious diseases
  • Immunomodulatory therapy

Related Links

Liles Lab

Publications

PubMed Bibliography

 

Mei, SHJ, Haitsma, JJ, Santos, CC dos, Deng, Y, Lai, PFH, Slutsky, AS, Liles WC, Stewart, DJ. Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis.. Am J Respir Crit Care Med. 2010; 182(8): 1047-57.

Ricciuto, DR, Santos, CC dos, Hawkes, M, Toltl, LJ, Conroy, AL, Rajwans, N, Lafferty, EI, Cook, DJ, Fox-Robichaud, A, Kahnamoui, K, Kain, KC, Liaw, PC, Liles WC. Angiopoietin-1 and angiopoietin-2 as clinically informative prognostic biomarkers of morbidity and mortality in severe sepsis. Crit Care Med. 2011; 39(4): 702-10.

dos Santos C, Murthy S, Hu P, Shan Y, Haitsma JJ, Mei SHJ, Stewart DJ, Liles WC. Network analysis of transcriptional responses induced by mesenchymal stem cell treatment of experimental sepsis. Am J Pathol.2012; 181(5): 1681-92.